Suppr超能文献

过度测量 pT1 结直肠癌黏膜下浸润深度的根本问题。

The essential problem of over-measuring the depth of submucosal invasion in pT1 colorectal cancer.

机构信息

Division of Pathology, Shizuoka Cancer Centre, Shizuoka Prefecture, Japan.

Division of Pathology, Jikei University School of Medicine, Tokyo, Japan.

出版信息

Virchows Arch. 2022 Feb;480(2):323-333. doi: 10.1007/s00428-021-03221-3. Epub 2021 Nov 5.

Abstract

A depth of submucosal invasion (DSI) of ≥1000 μm is an important risk factor for lymph node metastasis (LNM) in patients with submucosal invasive (pT1) colorectal cancer (CRC), according to the European Society of Gastrointestinal Endoscopy and the Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines. According to the latter, if the location of the muscularis mucosae in the invasive area is not confirmed, the DSI can be measured from the surface. In these cases, a 'remaining intramucosal lesion' (rIL), which is in the invasive area, is sometimes observed. To avoid over-measuring the DSI, we proposed a 'modified DSI' (mDSI), which excludes the rIL from the JSCCR DSI. We investigated the characteristics and effectiveness of the rIL and mDSI by grouping cases with polypoid growth (PG) and non-polypoid growth (NPG) histologically. Three hundred and thirty-nine consecutive patients with pT1 CRC were examined. LNM was detected in 37 cases. The distribution of the DSI and rIL was significantly higher in PG than in NPG cases (P<0.001). There was no difference in the mDSI distribution between the PG-/NPG-type cases. An rIL was observed in 39% (127/301) of cases, in which the location of the muscularis mucosae could not be determined or estimated and the mDIS could be estimated. In 13% (16/127) of cases, the mDSI was effective (JSCCR DSI ≥1000 and mDSI <1000 μm). Among these 16 cases, 11 (69%) did not have risk factors (mDSI, lymphovascular invasion, budding grade, or special histological types) and may have avoided unnecessary surgery.

摘要

黏膜下浸润深度(DSI)≥1000μm 是黏膜下浸润(pT1)结直肠癌(CRC)患者发生淋巴结转移(LNM)的重要危险因素,这符合欧洲胃肠道内镜学会和日本结直肠肿瘤学会(JSCCR)指南的标准。根据后者,如果不能确定浸润区黏膜肌层的位置,可以从表面测量 DSI。在这些情况下,有时会观察到位于浸润区的“残留黏膜内病变”(rIL)。为了避免过度测量 DSI,我们提出了“改良 DSI”(mDSI),即从 JSCCR 的 DSI 中排除 rIL。我们通过将组织学上具有息肉样生长(PG)和非息肉样生长(NPG)的病例进行分组,研究了 rIL 和 mDSI 的特征和有效性。共检查了 339 例连续的 pT1 CRC 患者,发现 37 例存在 LNM。PG 病例的 DSI 和 rIL 分布明显高于 NPG 病例(P<0.001)。PG-/NPG 型病例的 mDSI 分布无差异。在 301 例无法确定或估计黏膜肌层位置且可以估计 mDIS 的病例中,观察到 127 例(39%)存在 rIL。在 16 例(13%)mDSI 有效的病例中(JSCCR DSI≥1000μm,mDSI<1000μm)。在这 16 例病例中,有 11 例(69%)没有危险因素(mDSI、血管淋巴管侵犯、芽生分级或特殊组织学类型),可能避免了不必要的手术。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验